BioMaxima S.A. (WSE:BMX)
Poland
· Delayed Price · Currency is PLN 14.00
-0.60 (-4.11%)
Jun 6, 2025, 4:42 PM CET
BioMaxima Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 56.64 | 52.85 | 46.79 | 143.87 | 79.09 | 61.28 | Upgrade
|
| Revenue Growth (YoY) | 19.41% | 12.96% | -67.48% | 81.91% | 29.06% | 100.19% | Upgrade
|
| Cost of Revenue | 29.91 | 27.79 | 25.11 | 87.86 | 48.94 | 37.74 | Upgrade
|
| Gross Profit | 26.74 | 25.06 | 21.68 | 56.01 | 30.15 | 23.55 | Upgrade
|
| Selling, General & Admin | 20.29 | 19.46 | 18.22 | 17.49 | 15.29 | 11.85 | Upgrade
|
| Other Operating Expenses | 1.08 | 0.96 | 0.95 | 1.67 | -0.39 | 0.47 | Upgrade
|
| Operating Expenses | 24.87 | 23.78 | 21.48 | 21.11 | 16.49 | 14.17 | Upgrade
|
| Operating Income | 1.87 | 1.29 | 0.2 | 34.9 | 13.65 | 9.38 | Upgrade
|
| Interest Expense | -0.98 | -0.98 | -0.61 | -0.48 | -0.2 | -0.34 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0.14 | 0.8 | - | 0.1 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.12 | -0.12 | -0.2 | -0.01 | -0.06 | -0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | 0.1 | 0.77 | 0.69 | -0.67 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | 0.73 | 0.3 | 0.3 | 35.9 | 12.72 | 8.91 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0.02 | 0 | 0.06 | 0.11 | Upgrade
|
| Asset Writedown | -0.01 | -0.01 | -0.13 | -0.03 | - | 0.55 | Upgrade
|
| Pretax Income | 0.74 | 0.31 | 0.19 | 35.87 | 12.78 | 9.57 | Upgrade
|
| Income Tax Expense | -0.14 | -0.23 | -0.4 | 6.98 | 2.53 | 1.62 | Upgrade
|
| Earnings From Continuing Operations | 0.87 | 0.54 | 0.59 | 28.89 | 10.24 | 7.95 | Upgrade
|
| Net Income | 0.87 | 0.54 | 0.59 | 28.89 | 10.24 | 7.95 | Upgrade
|
| Net Income to Common | 0.87 | 0.54 | 0.59 | 28.89 | 10.24 | 7.95 | Upgrade
|
| Net Income Growth | 142.10% | -8.70% | -97.97% | 182.00% | 28.86% | - | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | -1.53% | -2.89% | -3.16% | -0.52% | 4.45% | 15.05% | Upgrade
|
| EPS (Basic) | 0.21 | 0.13 | 0.14 | 6.68 | 2.37 | 1.93 | Upgrade
|
| EPS (Diluted) | 0.21 | 0.13 | 0.14 | 6.48 | 2.29 | 1.85 | Upgrade
|
| EPS Growth | 145.86% | -5.99% | -97.91% | 182.97% | 23.78% | - | Upgrade
|
| Free Cash Flow | -2.98 | -2.42 | -16.49 | 27.19 | -4.61 | 2.09 | Upgrade
|
| Free Cash Flow Per Share | -0.71 | -0.58 | -3.82 | 6.10 | -1.03 | 0.49 | Upgrade
|
| Dividend Per Share | - | - | - | 0.500 | 0.450 | 0.250 | Upgrade
|
| Dividend Growth | - | - | - | 11.11% | 80.00% | - | Upgrade
|
| Gross Margin | 47.20% | 47.42% | 46.34% | 38.93% | 38.12% | 38.42% | Upgrade
|
| Operating Margin | 3.30% | 2.43% | 0.43% | 24.26% | 17.26% | 15.30% | Upgrade
|
| Profit Margin | 1.54% | 1.01% | 1.25% | 20.08% | 12.95% | 12.97% | Upgrade
|
| Free Cash Flow Margin | -5.26% | -4.58% | -35.24% | 18.90% | -5.83% | 3.41% | Upgrade
|
| EBITDA | 4.97 | 4.3 | 2.47 | 36.64 | 15.1 | 10.94 | Upgrade
|
| EBITDA Margin | 8.78% | 8.14% | 5.29% | 25.47% | 19.09% | 17.85% | Upgrade
|
| D&A For EBITDA | 3.1 | 3.02 | 2.27 | 1.74 | 1.45 | 1.56 | Upgrade
|
| EBIT | 1.87 | 1.29 | 0.2 | 34.9 | 13.65 | 9.38 | Upgrade
|
| EBIT Margin | 3.30% | 2.43% | 0.43% | 24.26% | 17.26% | 15.30% | Upgrade
|
| Effective Tax Rate | - | - | - | 19.47% | 19.82% | 16.90% | Upgrade
|
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.